Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Behavioral manifestations associated with multiple sclerosis.

M E Mahler1

  • 1Neurobehavior Program, Brentwood Division, West Los Angeles Department of Veterans Affairs Medical Center, California.

The Psychiatric Clinics of North America
|June 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultra-microscopic study of cosmetics.

Manufacturing chemist and aerosol news·2010
Same author

Does behavioral improvement with haloperidol or trazodone treatment depend on psychosis or mood symptoms in patients with dementia?

Journal of the American Geriatrics Society·2002
Same author

Major depressive disorder. Psychopathology, medical management and dental implications.

Journal of the American Dental Association (1939)·2001
Same author

Executive dysfunction in Alzheimer's disease: association with neuropsychiatric symptoms and functional impairment.

The Journal of neuropsychiatry and clinical neurosciences·1998
Same author

A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·1997
Same author

Cortical abnormalities associated with subcortical lesions in vascular dementia. Clinical and position emission tomographic findings.

Archives of neurology·1995
Same journal

Digital Mental Health: Progress but not Perfection.

The Psychiatric clinics of North America·2026
Same journal

Advances in Mental Health Technology.

The Psychiatric clinics of North America·2026
Same journal

The Future of Digital Mental Health: A Literature Review.

The Psychiatric clinics of North America·2026
Same journal

Assessment and Treatment of Posttraumatic Stress Disorder via Digital Mental Health Technology.

The Psychiatric clinics of North America·2026
Same journal

Treatment of Obsessive-Compulsive Disorder via Mental Health Technology.

The Psychiatric clinics of North America·2026
Same journal

Digital Mental Health Treatments for Depression.

The Psychiatric clinics of North America·2026
See all related articles

Multiple Sclerosis (MS) significantly impacts cognition and emotion, affecting intellect, memory, and executive functions. Management requires a multimodal approach including neurologic care, rehabilitation, and therapy.

Area of Science:

  • Neurology
  • Neuropsychology

Background:

  • Multiple Sclerosis (MS) is a chronic neurological disease.
  • Behavioral changes, including cognitive and emotional disturbances, are common in MS patients.

Purpose of the Study:

  • To summarize the range of behavioral manifestations in Multiple Sclerosis.
  • To highlight the impact of these changes on daily living and management strategies.

Main Methods:

  • Literature review of studies on cognitive and emotional changes in MS.
  • Analysis of reported prevalence and severity of impairments.

Main Results:

  • Cognitive impairments affect intellect (50%) and executive functions in MS patients.
  • Memory retrieval, concept formation, and emotional control disturbances are prevalent.

Related Experiment Videos

  • Depression is frequent, with occasional euphoria; psychosis is rare but bipolar disorder is more common.

    • Conclusions:

    • Behavioral disturbances are integral to Multiple Sclerosis, impacting quality of life.
    • Comprehensive management integrating neurologic care, cognitive rehabilitation, counseling, and pharmacotherapy is essential.